Table 3.
Attributes | Coefficienta | SE | P Value | 95% CI | |
---|---|---|---|---|---|
LB | HB | ||||
Progression Free Survival | |||||
11 months | 0.59 | 0.05 | 0.00 | 0.49 | 0.69 |
8 months | 0.11 | 0.03 | 0.00 | 0.04 | 0.17 |
5 months | −0.70 | 0.06 | 0.00 | −0.80 | −0.59 |
Disease Control Rate | |||||
High (90%) | 0.37 | 0.04 | 0.00 | 0.29 | 0.45 |
Middle (75%) | −0.15 | 0.03 | 0.00 | −0.21 | −0.09 |
Low (60%) | −0.22 | 0.04 | 0.00 | −0.30 | −0.14 |
Rash | |||||
None | −0.01 | 0.03 | 0.65 | −0.08 | 0.05 |
Moderate | 0.04 | 0.03 | 0.23 | −0.02 | 0.05 |
Severe | −0.02 | 0.03 | 0.51 | −0.09 | 0.04 |
Nausea and Vomiting | |||||
Mild | 0.11 | 0.03 | 0.00 | 0.05 | 0.18 |
Moderate | 0.02 | 0.03 | 0.54 | −0.04 | 0.08 |
Severe | −0.13 | 0.04 | 0.00 | −0.20 | −0.06 |
Tiredness | |||||
Mild | 0.22 | 0.04 | 0.00 | 0.15 | 0.29 |
Moderate | 0.07 | 0.03 | 0.03 | 0.01 | 0.13 |
Severe | −0.29 | 0.04 | 0.00 | −0.36 | −0.22 |
Administration Mode | |||||
Infusion | −0.05 | 0.02 | 0.03 | −0.09 | −0.01 |
Oral | 0.05 | 0.02 | 0.03 | 0.01 | 0.09 |
Costs, CN¥ | −0.04 | 0.00 | 0.00 | −0.04 | −0.03 |
Note: aCoefficients represent the change in utility for a respondent for a specific level of a given attribute.
Abbreviations: SE, standard error; CI, confidence interval; CN, Chinese yuan; LB, low bound; HB, high bound.